Gastroösophageale Refluxkrankheit – Ergebnisse einer - DGVS

Leitlinie 174
11 Galmiche JP, Barthelemy P et al. Treating the symptoms of gastrooesophageal
reflux disease: a double-blind comparison of omeprazole
and cisapride. Aliment Pharmacol Ther 1997; 11: 765 – 773
12 Lind T, Havelund T et al. Heartburn without oesophagitis: efficacy of
omeprazole therapy and features determining therapeutic response.
Scand J Gastroenterol 1997; 32: 974 –979
13 Smout AJPM. Endoscopic-negative acid reflux disease. Aliment Pharmacol
Ther 1997; 11 (suppl): 81 –85
14 Dent J, Brun J, Fendrick A et al. An evidence-based appraisal of reflux
disease management – the Genval Workshop Report. Gut 1999; 44:
S1–S16
15 Hotz J, Madisch A, Classen M et al. Internationaler Konsens zur Refluxkrankheit
der Speiseröhre. Dtsch Med Wschr 2000; 125: 1308 – 1312
16 Schindlbeck NE, Wiebecke B, Klauser AG et al. Diagnostic value of histology
in non-erosive gastro-oesophageal reflux disease. Gut 1996;
39: 151 –154
17 Ollyo JB, Gontollier C, Brossard E et al. La nouvelle classification de
Savary des oesophagites de reflux. Acta Endoscopica 1992; 22: 307
18 Armstrong D. Endoscopic evaluation of gastro-esophageal reflux
disease. Yale J biol Med 1999; 72: 93 –100
19 Jones MP, Sloan SS, Rabine JC et al. Hiatal hernia size is the dominant
determinant of esophagitis presence and severity in gastroesophageal
reflux disease. Am J Gastroenterol 2001; 96 (6): 1711 – 1717
20 Öberg S, Peters JH, DeMeester TR et al. Endoscopic grading of the gastroesophageal
valve in patients with symptoms of gastroesophageal
reflux disease (GERD). Surg Endosc 1999; 13: 1184 – 1188
21 Achem SR. Endoscopy-negative gastroesophageal reflux disease. The
hypersensitive esophagus. Gastroenterol Clin North America 1999;
28: 893–904
22 Galmiche JP, des Varannes SB. Endoscopy-negative reflux disease.
Curr Gastroenterol Rep 2001; 3: 206 – 214
23 Lundell LR, Dent J, Bennett JR et al. Endoscopic assessment of oesophagitis:
clinical and functional correlates and further validation of
the Los Angeles classification. Gut 1999; 45: 172 – 180
24 Vieth M, Stolte M. Can an endoscopically negative reflux disease be
histologically diagnosed? Z Gastroenterol 2000; 38: 817 – 818
25 Ismail-Beigi F, Horton PF, Pope CE. Histological consequences of gastroesophageal
reflux in man. Gastroenterology 1970; 58: 163 – 174
26 Seefeld U, Krejs GJ, Siebenmann RE et al. Esophageal histology in gastroesophageal
reflux: Morphometric findings in suction biopsies. Dig
Dis Sci 1977; 22: 956 – 964
27 Collins JSA, Watt PCH, Hamilton PW et al. Assessment of oesophagitis
by histology and morphometry. Histopathology 1989; 14: 381 – 389
28 Morrow JB, Vargow JJ, Goldblum JR et al. The Ringed Esophagus: Histological
Features of GERD. Am J Gastroenterol 2001; 96: 984 – 989
29 Bytzer P, Moller Hansen J, de Schaffalitzky Muckadell OB. Empirical
H2-blocker therapy or prompt endoscopy in management of dyspepsia.
Lancet 1994; 343: 811 – 816
30 Silverstein MD, Petterson T, Talley NJ. Initial endoscopy or empirical
therapy with or without testing for Helicobacter pylori for dyspepsia:
a decision analysis. Gastroenterology 1996; 110: 72– 83
31 Fass R, Fennerty MB, Ofman JJ et al. The clinical and economic value of
a short course of omeprazole in patients with noncardiac chest pain.
Gastroenterology 1998; 115: 42 – 49
32 Jaup BH. Effective acid inhibition as a diagnostic tool for gastroesopheagel
reflux disease. Gut 1995; 37 (Suppl 2): A36
33 Johnsson F, Weyvadt L, Solhaug JH et al. One week omeprazole treatment
as a diagnostic test for gastro-oesophageal reflux disease. Gut
1996; 39 (Suppl 1): A39
34 Numans ME, Lau J, de Wit NJ et al. Short-term treatment with protonpump
inhibitors as a test for gastroesophageal reflux disease: a metaanalysis
of diagnostic test characteristics. Ann Intern Med 2004; 140:
518 – 527
35 Schenk BE, Kuipers EJ, Klinkenberg-Knol EC et al. Omeprazole as a
diagnsotiv tool in gastroesophageal reflux disease. Am J Gastroenterol
1997; 92: 1997– 2000
36 Schindlbeck NE, Klauser AG, Voderholzer WA et al. Empiric therapy
for gastroesophageal reflux disease. Arch Intern Med 1995; 155:
1808 – 12
37 Zierer MD, Sanowski RA, Young MF et al. Can a single dose of omeprazole
be used to identify gastroesophageal reflux and acid-related
chest pain? Am J Gastroenterology 1993; 88: 1501
Leitlinie … Z Gastroenterol 2005; 43: 165 – 194 · DOI 10.1055/s-2005-857872
38 Fass R, Ofman JJ, Sampliner RE et al. The omeprazole test is as sensitive
as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal
reflux disease in symptomatic patients with erosive oesophagitis. Aliment
Pharmacol Ther 2000; 14: 389–396
39 Leite LP, Johnston BT, Just RJ et al. Persistent acid secretion during
omeprazole therapy: a study of gastric acid profiles in patients demonstating
failure of omeprazole therapy. Am J Gastroenterol 1996;
91 (8): 1527 – 1531
40 Maton PN, Orlando R, Joelsson B. Efficacy of omeprazole versus ranitidine
for symptomatic treatment of poorly responsive acid reflux
disease – a prospective controlled trial. Aliment Pharmacol Ther 1999;
13: 819 – 826
41 Richter JE, Kahrilas PJ, Johanson J et al. Efficacy and safety of esomeprazole
compared with omeprazole in GERD patients with erosive
esophagitis: a randomized controlled trial. Am J Gastroenterol 2001;
96: 656 – 665
42 Festen HPM, Schenk E, Tan G et al. Omeprazole versus high-dose ranitidine
in mild gastroesophageal reflux disease: short- and long-term
treatment. Am J Gastroenterol 1999; 94: 931 – 936
43 Watson RGP, Tham TCK, Johnston BT et al. Double blind cross-over
placebo controlled study of omeprazole in the treatment of patients
with reflux symptoms and physiological levels of acid reflux – the
„sensitive oesophagus“. Gut 1997; 40: 587 – 590
44 Ergun GA, Kahrilas PJ. Clinical applications of esophageal manometry
and pH monitoring. Am J Gastroenterol 1996; 91: 1077 – 1089
45 Locke GR, Talley NJ. 24-hour monitoring for gastro-oesophageal reflux
disease. Lancet 1993; 342: 1246– 1247
46 Richter JE. Typical and atypical presentations of gastroesophageal reflux
disease. The role of esophageal testing in diagnosis and management.
Gastroenterol Clin North Am 1996; 25: 75 – 102
47 Fuchs KH, DeMeester TR, Albertucci M. Specificity and sensitivity of
objective diagnosis of gastroesophageal reflux disease. Surgery 1987;
102: 575 – 580
48 Waring JP, Hunter JG, Oddsdottir M et al. The preoperative evaluation
of patients considered for laparoscopic antireflux surgery. Am J Gastroenterol
1995; 90: 35–38
49 Ghillebert G, Demeyere AM, Janssens J et al. How well can quantitative
24-hour intraesophageal pH monitoring distinguish various degrees
of reflux disease? Dig Dis Sci 1995; 40: 1317 –1324
50 Ask P, Edwall G, Johansson KE. Accuracy and choice of procedures in
24-hour oesophageal pH monitoring with monocrystalline antimony
electrodes. Med Biol Eng Comput 1986; 24: 602 – 608
51 Richter JE, Bradley LA, DeMeester TR et al. Normal 24-hr ambulatory
esophageal pH values. Influence of study center, pH electrode, age,
and gender. Dig Dis Sci 1992; 37: 849 – 856
52 Vandenplas Y, Helven R, Goyvaerts H. Comparative study of glass and
antimony electrodes for continuous oesophageal pH monitoring. Gut
1991; 32: 708–712
53 Dobhan R, Castell DO. Normal and abnormal esophageal acid exposure:
results of ambulatory dual-probe monitoring. Am J Gastroenterol
1993; 88: 25 –29
54 Wo JM, Hunter JG et al. Dual-channel ambulatory esophageal pH monitoring.
A useful diagnostic tool? Dig Dis Sci 1997; 42: 2222 – 2226
55 Johnson LF, DeMeester TR. Twenty-four-hour pH monitoring of the
distal esophagus. A quantitative measure of gastroesophageal reflux.
Am J Gastroenterol 1974; 62: 325 – 332
56 DeVault KR, Castell DO. A simplified technique for accurate placement
of ambulatory pH probes. Am J Gastroenterol 1991; 86: 380 – 381
57 Kahrilas PJ, Quigley EM. Clinical esophageal pH recording a technical
review for pratice guideline development. Gastroenterology 1996;
110: 1982 – 1996
58 Dhiman RK, Saraswat VA, Mishra A et al. Inclusion of supine period in
short-duration pH monitoring is essential in diagnosis of gastroesophageal
reflux disease. Dig Dis Sci 1996; 41: 764 – 772
59 Dinelli M, Passaretti S, Di FI et al. Area under pH 4: a more sensitive
parameter for the quantitative analysis of esophageal acid exposure
in adults. Am J Gastroenterol 1999; 94: 3139 –3144
60 Schindlbeck NE, Heinrich C, Konig A et al. Optimal thresholds, sensitivity
and specificity of long-term pH-metry for the detection of gastroesophageal
reflux disease. Gastroenterology 1987; 93: 85 – 90
61 Schindlbeck NE, Ippisch H, Klauser AG et al. Which pH threshold is
best in esophageal pH monitoring? Am J Gastroenterol 1991; 86:
1138 – 1141